Nilotinib

Nilotinib, a novel, selective BCR-ABL inhibitor, fits into the ATP-binding site of the BCR-ABL protein with higher affinity than imatinib. Nilotinib is not only more potent than imatinib against wild-type BCR-ABL (IC50 < 30 nM), but also significantly active against 32/33 imatinib-resistant BCR-ABL mutants. Nilotinib was as potent as imatinib in inducing apoptosis (IC50 = 0.54 nM) and inhibiting proliferation (IC50 = 0.20 nM) of EOL-1 cells.

Product Name Nilotinib 25mg
SKU Number 1100190252
Product Size 25mg
List Price $43.00 USD
  Quantity    
Product Name Nilotinib 100mg
SKU Number 1100191002
Product Size 100mg
List Price $79.00 USD
  Quantity    
Product Name Nilotinib 300mg
SKU Number 1100193002
Product Size 300mg
List Price $202.00 USD
  Quantity    
Product Name Nilotinib 1g
SKU Number 1100190013
Product Size 1g
List Price $479.00 USD
  Quantity    
Product Name Nilotinib 2g
SKU Number 1100190023
Product Size 2g
List Price $809.00 USD
  Quantity    

Add to Cart

Molecular Formula: C28H22F3N7O
Molecular Weight: 529.52 g/mol
CAS Number: 641571-10-0
Apperance: Pale yellow to off-white powder
Solubility: soluble in DMSO at 50 mg/mL; very poorly soluble in ethanol and water
Purity: 99%
Storage: -20ºC

MATERIAL SAFETY DATA SHEET

TRADENAME: Nilotinib
DATE OF ISSUE:Feb 10.2011
SKU#:1100190252(25mg),1100191002(100mg),1100193002(300mg),1100190013(1g),1100190023(2g)

SECTION I:PRODUCT AND MANUFACTURER INFORMATION

TRADE NAME: Nilotinib
Supplier: Eton Bioscience Inc., 5820 Oberlin Drive, Suite 108, San Diego, CA 92121
Information Telephone:800.758.1630
Emergency Telephone: 800.758.1630

SECTION II: COMPOSITION / INFORMATION ON INGREDIENTS

Chemical Name: 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
Synonyms:
Hazardous Ingredient: Nilotinib
Molecular Weight: 529.52
Molecular Formula: C28H22F3N7O
CAS Number:641571-10-0

SECTION III:HAZARD IDENTIFICATION

Hazard Description: Pharmaceutical product
Avoid contact with skin and eyes; avoid inhalation; do not take internally
Exposure may cause nausea, vomiting, diarrhea, headache fatigue, and rash
Exposure may be harmful to developing fetus
Prolonged or repeated exposure may cause liver toxicity

SECTION IV:FIRST AID MEASURES

After Inhalation: If inhaled, remove to fresh air; if breathing is difficult, give oxygen; if breathing stops, give artificial respiration
After skin contact: flush with copious amounts of water; remove contaminated clothing and shoes; call a physician
After eye contact: check for and remove contact lenses and flush with copious amounts of water; assure adequate flushing by separating the eyelids with fingers; call a physician
After swallowing: if swallowed, wash out mouth with copious amounts of water; call a physician

SECTION V:FIREFIGHTING MEASURES

Suitable extinguishing agents: water spray, carbon dioxide, dry chemical powder or foam
Protective equipment: wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes.
Unusual fire hazard: may emit toxic fumes under fire conditions such as carbon monoxide, etc

SECTION VI:ACCIDENTAL RELEASE MEASURES

Person-related safety precautions: cordon off area of spill; wear self-contained breathing apparatus, protective clothing and heavy rubber gloves
Measures for cleaning/collecting: absorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); decontaminate surfaces and equipment by scrubbing with alcohol; dispose of contaminated material according to Section 13

SECTION VII:HANDLING AND STORAGE

Information for safe handling: avoid inhalation and contact with skin, eyes, and clothing; material may be an irritant
Storage: store solid and solutions at -20ºC

SECTION VIII:EXPOSURE CONTROLS / PERSONAL PROTECTION

Personal protective equipment as follows:
Breathing equipment: NIOSH/MSHA-approved respirator
Protection of hands: chemical-resistant rubber gloves
Eye protection: chemical safety goggles

SECTION IX:PHYSICAL AND CHEMICAL PROPERTIES

Form: solid powder
Color: off-white to pale yellow
Odor: none
Melting point/Melting range: 230-242 ºC
Danger of explosion: none
Solubility in / Miscibility with water: very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility
Solvent content: none
Organic solvents: soluble in DMSO at 50 mg/mL; very poorly soluble in ethanol

SECTION X:STABILITY AND REACTIVITY

Stability: stable if stored as directed; avoid strong oxidizing agents
Thermal decomposition / conditions to be avoided: protect from light and heat
Dangerous products of decomposition: thermal decomposition may produce toxic gases such as carbon monoxide and carbon dioxide, and nitrogen oxides

SECTION XI:TOXICOLOGICAL INFORMATION

RTECS No: not available
Acute toxicity: not known
Primary irritant effect:
On the skin: not known; may be an irritant
On the eye: not known; may be an irritant
Reproductive effects: can cause harm to the developing fetus

SECTION XII:ECOLOGICAL INFORMATION

General notes: no data available

SECTION XIII:DISPOSAL CONSIDERATIONS

Dispose of in accordance with prevailing country, federal, state and local regulations

SECTION XIV:TRANSPORT INFORMATION

DOT:
Proper shipping name: none
Non-Hazardous for transport: this substance is considered to be non-hazardous for transport
IATA class:
Proper shipping name: none
Non-Hazardous for transport: this substance is considered to be non-hazardous for transport

SECTION XV:REGULATORY INFORMATION

Code letter and hazard designation of product:
EU Risk And Safety phrases:
S22: Do not breathe dust
S24-25: Avoid contact with skin and eyes
S36/37/39: Wear suitable protective clothing, gloves, and eye/face protection
R61: May cause harm to unborn child

SECTION XVI:OTHER INFORMATION

The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty ofn merchantability or any other warranty, express or implied, with respect to such information. Users should make their own investigations to determine the suitability of the information for their particular purposes. Eton Bioscience Inc. shall not be held liable for any damages or other consequences resulting from handling or from contact with the above product.

END OF DATASHEET

Copyright © 2003-2014

All Rights Reserved

Eton Bioscience, Inc.
5820 Oberlin Drive, Suite 108
San Diego, CA 92121
DNA Sequencing
Specialty DNA Sequencing
Direct Sequencing
Genomic Services
Fragment Analysis
Mammilian Cell Expression
Primer Walking
Peptide Synthesis
Antibody Services
DNA Prep Service